Claims for Patent: RE46363

✉ Email this page to a colleague

Summary for Patent: RE46363

Title:	Dial-down mechanism for wind-up pen
Abstract:	The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising dial-up cam arranged to receive and engage with a dial-up key, wherein the dial-up cam and the dial-up key are adapted to, upon rotation of a dose setting member in a first direction, cooperate to strain the torsion spring of the injection device, and a dial-down cam arranged to receive and engage with a dial-down key, wherein the dial-down cam and the dial-down key are adapted to, upon rotation of the dose setting member in a second direction, cooperate to release the torsion spring of the injection device, the second rotation direction being opposite to the first rotation direction.
Inventor(s):	Moeller Claus Schmidt, Enggaard Christian Peter, Radmer Bo, Markussen Tom Hede
Assignee:	Novo Nordisk A/S
Application Number:	US14091774
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE46363
Patent Claims:

Details for Patent RE46363

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	⤷ Subscribe	2033-11-27
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	⤷ Subscribe	2033-11-27
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Subscribe	2033-11-27
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	⤷ Subscribe	2033-11-27
Novo Nordisk Inc.	FIASP	insulin aspart	Injection	208751	September 29, 2017	⤷ Subscribe	2033-11-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.